Closing soon Source · Language: Polski

Poland · Medical equipment, pharmaceuticals and personal care products

Official subject Polski

Dostawa produktu leczniczego Eleksakaftor 100 mg + Iwakaftor 75 mg + Tezakaftor 50 mg, rozliczanego z programu lekowego B.112.

Country and CPV sector cues are shown in your language; the official subject remains in its source language.

Instytut Gruźlicy i Chorób Płuc · Poland

Deadline Aug 24, 2026, 6:00 AM UTC
Estimated valueNot announced
PublishedJul 20, 2026
Open official notice ↗

Opportunity summary

What is being procured?

Przedmiotem zamówienia jest dostawa produktu leczniczego rozliczanego z pakietu programów lekowych B.112: Eleksakaftor + Iwakaftor + Tezakaftor, tabletki powlekane; 1 tabl. zawiera: 75 mg iwakaftoru, 50 mg tezakaftoru, 100 mg eleksakaftoru; 56 tabl – 735 op.

Source and reliability

Source: official TED notice 498292-2026, last checked Aug 21, 2026, 2:05 PM. The original publication remains authoritative.

Data is restructured for easier reading. The official notice and procurement documents always prevail.